Learn More
Medchemexpress LLC (Rac)-minzasolmin | 1802518-63-3 | 99.9% | 425.59 | C23H31N5OS | 5MG

Supplier: Medchemexpress LLC HY1252875MG
(Rac)-Minzasolmin is a racemic small-molecule inhibitor of α-synuclein misfolding with oral bioavailability and blood-brain barrier penetration. It modulates early-stage α-synuclein aggregation and is used in preclinical in vitro and in vivo studies to reduce pathological α-synuclein accumulation in models of Parkinson's disease and related synucleinopathies.
- High purity, typically reported as 99.9%.
- Blood-brain barrier permeable small molecule.
- Racemic composition for preclinical comparison of enantiomeric activity.
- Molecular formula C23H31N5OS and molecular weight 425.59 g·mol⁻¹.
- Suitable for both in vitro assays and in vivo model studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.